Pathogenesis of mallory body formation:studies using the drug-primed mouse model
スポンサーリンク
概要
著者
-
WAN Yu-Jui
Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center
-
NAGAO YASUYUKI
Department of Gastroenterology, Matsushita Memorial Hospital
-
Wan Yu-jui
Department Of Pathology Harbor-ucla Medical Center
-
French Samuel
Department Of Pathology Harbor-ucla Medical Center
-
French Samuel
Department Of Pathology And Surgery Harbor-ucla (university Of California Los Angeles) Medical Cente
-
Nagao Yasuyuki
Kyoto Prefecture University
-
Nagao Yasuyuki
Department Of Gastroenterology Matsushita Memorial Hospital
-
FRENCH Barbara
Department of Pathology, Harbor-UCLA Medical Center
-
French Barbara
Department Of Pathology Harbor-ucla Medical Center
-
YUAN Qi.-X.
Department of Pathology,Harbor-UCLA Medical Center
-
Yuan Qi.-x.
Department Of Pathology Harbor-ucla Medical Center
-
FRENCH Barbara
Department of Pathology,Harbor-UCLA Medical Center
関連論文
- Gender Disparity of Hepatic Lipid Homoeostasis Regulated by the Circadian Clock
- Effects of a Sequential Combination of Hyperthermia and Gemcitabine in the Treatment of Advanced Unresectable Pancreatic Cancer : A Retrospective Study
- Regulation of peroxisome proliferator activated receptor α-mediated pathways in alcohol fed cytochrome P450 2E1 deficient mice
- Pathogenesis of mallory body formation:studies using the drug-primed mouse model
- Mouse model of hepatocellular hyperplastic nodule formation characterization of mRNA expression
- Regulation of liver cell polarity by retinoic acid in vitro: bile canaliculi formation
- Mallory body and empty cell in hepatitis C
- The role of hypoxia in the pathogenesis of alcoholic liver disease
- Melanocytic differentiation in a solid pseudopapillary tumor of the pancreas
- Hepatocyte nuclear factor 1 mediates the cell density associated induction of the α-fetoprotein gene
- The C-681G Polymorphism of the PPAR-γ Gene Is Associated with Susceptibility to Non-Alcoholic Fatty Liver Disease
- Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy